Goldhaber, Samuel Z. http://orcid.org/0000-0002-6450-0448
Ageno, Walter
Casella, Ivan B.
Chee, Kok Han
Schellong, Sebastian
Singer, Daniel E.
Voccia, Isabelle
Tang, Wenbo
Schulman, Sam
Funding for this research was provided by:
Boehringer Ingelheim
Article History
Accepted: 26 April 2021
First Online: 28 August 2021
Declarations
:
: SZG has received research support from Boehringer Ingelheim (BI), Bristol-Myers Squibb (BMS), Boston Scientific BTG, Daiichi Sankyo, Janssen, Agile, and the US National Heart Lung and Blood Institute. He is a consultant for Bayer, BI, Agile, and Boston Scientific. WA has participated in advisory boards for Bayer, Portola, Aspen, Sanofi, Daiichi Sankyo, BI, and has received travel or research support from Bayer, Portola, Aspen, Janssen, Sanofi, Daiichi Sankyo, BMS, Pfizer, and BI. IBC has received speaker and/or consultancy fees from BI, Bayer, Daiichi Sankyo, Pfizer, and Amgen. KHC has received speaker fees from BI, BMS, and Pfizer. SSche has received speaker fees from Bayer HealthCare, BI, BMS, Daiichi Sankyo, GlaxoSmithKline (GSK), Sanofi, and LEO Pharma. He has received consultancy fees from Bayer HealthCare, BI, Daiichi Sankyo, GSK, and Sanofi. DES has received honoraria from BI, BMS, Merck, J&J, and Pfizer, and research support from BI and BMS. IV and WT are employees of BI. SSchu has received honoraria from Alnylam, BI, Bayer HealthCare, Daiichi Sankyo, Pfizer, and Sanofi, and research support from BI and Octapharma.
: Approvals from Ethics Committees or Institutional Review Boards were obtained.
: Written informed consent to participate was obtained.